– Building beyond remote patient monitoring into digital biomarkers and therapeutics, UK-headquartered global digital health company Medopad is renamed Huma

– Huma acquires wearable technology and AI businesses BioBeats and Tarilian Laser Technologies (TLT) to add mental health and cardiovascular support to its remote patient monitoring platform

– Huma appoints former UK Health Minister The Right Honourable Alan Milburn to chairman of its board of directors, who also serves as Chairman of the European Advisory Board at Bridgepoint Capital and Chair of PwC’s UK Health Industry Oversight Board

– With its new technologies and brand, Huma shares its mission to discover digital biomarkers, making sense of the data our bodies produce in a move towards proactive and preventative health

LONDON, April 16, 2020 /PRNewswire/ — Today, Medopad is announcing that

Read More At Article Source | Article Attribution